PubRank
Search
About
Effect of DMR in the Treatment of NASH (DMR_NASH_001)
Clinical Trial ID NCT03536650
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT03536650
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Aliment Pharmacol Ther
2011
7.91
2
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
Gastroenterology
2012
5.47
3
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
Hepatology
2010
4.76
4
The burden of liver disease in Europe: a review of available epidemiological data.
J Hepatol
2013
4.05
5
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
Ann Surg
2006
3.97
6
Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.
Ann Surg
2004
3.23
7
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Gastroenterology
2015
3.17
8
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.
Diabetes Care
2009
1.41
9
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Obes Surg
2005
1.20
10
Bile acid receptors in non-alcoholic fatty liver disease.
Biochem Pharmacol
2013
0.99
11
Small intestinal alterations in severely obese hyperglycemic subjects.
J Clin Endocrinol Metab
2010
0.92
12
High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats.
Diabetologia
2010
0.91
13
Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.
Obesity (Silver Spring)
2012
0.89
14
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study.
Diabetes Care
2016
0.82
15
Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
Clin Liver Dis
2016
0.79
16
Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets.
World J Hepatol
2015
0.77
17
EndoBarrier Gastrointestinal Liner in Type 2 Diabetic Patients Improves Liver Fibrosis as Assessed by Liver Elastography.
Exp Clin Endocrinol Diabetes
2016
0.75
18
Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis.
Front Physiol
2016
0.75
19
Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis.
Hepatology
2016
0.75
Next 100